Last reviewed · How we verify
MEBO Wound Ointment
MEBO Wound Ointment promotes wound healing through a combination of herbal extracts and oils that enhance tissue regeneration and reduce inflammation.
MEBO Wound Ointment promotes wound healing through a combination of herbal extracts and oils that enhance tissue regeneration and reduce inflammation. Used for Burn wounds, Traumatic wounds, Surgical wounds.
At a glance
| Generic name | MEBO Wound Ointment |
|---|---|
| Sponsor | Skingenix, Inc. |
| Drug class | Topical wound healing agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology / Wound Care |
| Phase | FDA-approved |
Mechanism of action
MEBO (Moist Exposed Burn Ointment) is a traditional Chinese medicine-based topical formulation containing sesame oil, beeswax, and various herbal components. It works by maintaining a moist wound environment that promotes epithelialization, reduces bacterial colonization, and minimizes scar formation while providing antimicrobial and anti-inflammatory effects.
Approved indications
- Burn wounds
- Traumatic wounds
- Surgical wounds
- Chronic wounds
Common side effects
- Local irritation or sensitization
- Allergic contact dermatitis
Key clinical trials
- A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot) (PHASE2)
- A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers (PHASE2)
- A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers (PHASE2)
- Zinc Oxide VS MEBO (PHASE4)
- A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis (PHASE3)
- Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure (PHASE2)
- Effect of Mebo Dressing Versus Standard Care on Managing Donor and Recipient Sites of Split-thickness Skin Graft (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |